Format

Send to

Choose Destination
Biomark Med. 2012 Aug;6(4):391-400. doi: 10.2217/bmm.12.49.

Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challenges.

Author information

1
Centre for Statistical Methodology, London School of Hygiene & Tropical Medicine, Keppel Street, London, UK.

Abstract

New proposed criteria for the clinical diagnosis of Alzheimer's disease increasingly incorporate biomarkers, most of which are normally measured on a continuous scale. Operationalizing such criteria thus requires continuous biomarkers to be dichotomized, which in turns requires the selection of a cut-point at which to dichotomize. In this article, we review the statistical principles underlying the choice of cut-points, describe some of the most commonly adopted statistical approaches used to estimate cut-points, highlight potential pitfalls in some of the approaches and characterize in what sense the estimated cut-point from each approach is optimal. We also emphasize that how a cut-point is selected must be made in reference to how the resulting dichotomized biomarker is to be used, and in particular what actions will follow from a positive or negative test result.

PMID:
22917141
DOI:
10.2217/bmm.12.49
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Atypon Icon for London School of Hygiene and Tropical Medicine
Loading ...
Support Center